Laboratoires [ALEMG] vs Bastide le Confort [BLC] Detailed Stock Comparison
Laboratoires
Euronext
Loading...
Bastide le Confort
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Laboratoires wins in 6 metrics, Bastide le Confort wins in 12 metrics, with 0 ties. Bastide le Confort appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Laboratoires | Bastide le Confort | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.20 | 24.48 | Bastide le Confort |
| Price-to-Book Ratio | 0.73 | 2.77 | Laboratoires |
| Debt-to-Equity Ratio | 48.76 | 541.81 | Laboratoires |
| PEG Ratio | 10.58 | 9.37 | Bastide le Confort |
| EV/EBITDA | 0.00 | 6.64 | Laboratoires |
| Profit Margin (TTM) | -16.78% | 0.32% | Bastide le Confort |
| Operating Margin (TTM) | 5.27% | 9.53% | Bastide le Confort |
| EBITDA Margin (TTM) | 5.27% | 9.53% | Bastide le Confort |
| Return on Equity | -31.26% | 10.46% | Bastide le Confort |
| Return on Assets (TTM) | 0.58% | 4.53% | Bastide le Confort |
| Free Cash Flow (TTM) | $-2.08M | $37.29M | Bastide le Confort |
| 1-Year Return | -19.89% | 30.88% | Bastide le Confort |
| Price-to-Sales Ratio (TTM) | 0.33 | 0.38 | Laboratoires |
| Enterprise Value | $0 | $601.51M | Bastide le Confort |
| EV/Revenue Ratio | 0.00 | 1.11 | Laboratoires |
| Revenue per Share (TTM) | $13 | $72 | Bastide le Confort |
| Earnings per Share (Diluted) | $0.15 | $1.16 | Bastide le Confort |
| Beta (Stock Volatility) | 0.28 | 0.87 | Laboratoires |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Laboratoires vs Bastide le Confort Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Laboratoires | -0.47% | -1.40% | -3.20% | 3.68% | 0.71% | -3.64% |
| Bastide le Confort | 2.34% | 2.71% | -7.34% | -2.74% | 8.40% | 20.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Laboratoires | -19.89% | -28.91% | -53.77% | -40.42% | -13.67% | -13.67% |
| Bastide le Confort | 30.88% | -23.24% | -36.47% | 42.50% | 340.31% | 340.31% |
Performance & Financial Health Analysis: Laboratoires vs Bastide le Confort
| Metric | ALEMG | BLC |
|---|---|---|
| Market Information | ||
| Market Cap | €12.06M | €207.60M |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 172 | 5,572 |
| 90 Day Avg. Volume | 169 | 4,529 |
| Last Close | €4.23 | €28.40 |
| 52 Week Range | €3.39 - €5.44 | €17.30 - €33.30 |
| % from 52W High | -22.24% | -14.71% |
| All-Time High | €28.40 (Feb 24, 2020) | €61.40 (Jan 01, 2018) |
| % from All-Time High | -85.11% | -53.75% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.94% | 0.04% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.17% | 0.00% |
| Operating Margin (TTM) | 0.05% | 0.10% |
| Return on Equity (TTM) | -0.31% | 0.10% |
| Debt to Equity (MRQ) | 48.76 | 541.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €5.80 | €10.26 |
| Cash per Share (MRQ) | N/A | €4.22 |
| Operating Cash Flow (TTM) | €-5,937,000 | €112.14M |
| Levered Free Cash Flow (TTM) | €-6,108,078 | €17.46M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | €0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Laboratoires vs Bastide le Confort
| Metric | ALEMG | BLC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.20 | 24.48 |
| Forward P/E | 10.58 | 9.37 |
| PEG Ratio | 10.58 | 9.37 |
| Price to Sales (TTM) | 0.33 | 0.38 |
| Price to Book (MRQ) | 0.73 | 2.77 |
| Market Capitalization | ||
| Market Capitalization | €12.06M | €207.60M |
| Enterprise Value | €0 | €601.51M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.00 | 1.11 |
| Enterprise to EBITDA | 0.00 | 6.64 |
| Risk & Other Metrics | ||
| Beta | 0.28 | 0.87 |
| Book Value per Share (MRQ) | €5.80 | €10.26 |
Financial Statements Comparison: Laboratoires vs Bastide le Confort
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALEMG | BLC |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALEMG | BLC |
|---|---|---|
| Cash & Equivalents | €15.18M | €23.62M |
| Total Current Assets | €37.65M | €208.92M |
| Total Current Liabilities | €10.66M | €216.21M |
| Long-Term Debt | €8.04M | €342.73M |
| Total Shareholders Equity | €16.48M | €80.73M |
| Retained Earnings | €-2.20M | €66.95M |
| Property, Plant & Equipment | €1.41M | €171.41M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALEMG | BLC |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALEMG | BLC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 172 | 5,572 |
| Average Daily Volume (90 Day) | 169 | 4,529 |
| Shares Outstanding | 2.85M | 7.30M |
| Float Shares | 994,937 | 3.35M |
| % Held by Insiders | 0.64% | 0.56% |
| % Held by Institutions | 0.02% | 0.11% |
Dividend Analysis & Yield Comparison: Laboratoires vs Bastide le Confort
| Metric | ALEMG | BLC |
|---|---|---|
| Last 12-Month Dividend | €0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | €0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | €0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |